Tech Company Financing Transactions
CapeHaven Funding Round
Private investors participated in a $10 million venture round for CapeHaven. The round was recorded on 5/14/2026.
Transaction Overview
Company Name
Announced On
5/14/2026
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding supports the following initiatives: Expansion of the CapeHaven scientific and venture creation team; Evaluation and advancement of early-stage therapeutic opportunities emerging from academic laboratories; Launch of Brainstorm Cancer Therapeutics, an oncology-focused discovery company.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Trap Falls Road 106
Shelton, CT 06484
USA
Shelton, CT 06484
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Bridging the gap from academic discoveries to commercialization. We specialize in advancing early stage therapeutics from academia to a financeable business that will deliver life-saving therapies to patients in need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Ranjit Bindra
Founder
Mike Dillon
Founder
Seth Herzon
Founder
Kevin Rakin
Browse more venture capital transactions:
Prev: 5/14/2026: Onramp venture capital transaction
Next: 5/14/2026: Origin Lab venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs